Reply to "Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+breast cancer"

被引：0
|
作者：
Cao, Lifen [1 ]
Stabellini, Nickolas [2 ]
Amin, Amanda L. [3 ]
Montero, Alberto J. [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Med Ctr,Dept Med,Div Hematol & Oncol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Med Ctr,Dept Surg,Div Surg Oncol, Cleveland, OH 44106 USA
来源：
CANCER | 2022年 / 128卷 / 16期
关键词：
D O I：
10.1002/cncr.34339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3130 / 3130
页数：1
相关论文
共 50 条
  • [31] Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
    Alina M. Mateo
    Todd A. Pezzi
    Mark Sundermeyer
    Cynthia A. Kelley
    V. Suzanne Klimberg
    Christopher M. Pezzi
    Annals of Surgical Oncology, 2017, 24 : 1050 - 1056
  • [32] Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
    Mateo, Alina M.
    Pezzi, Todd A.
    Sundermeyer, Mark
    Kelley, Cynthia A.
    Klimberg, V. Suzanne
    Pezzi, Christopher M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) : 1050 - 1056
  • [33] BENEFIT OF ADJUVANT TRASTUZUMAB WITH CHEMOTHERAPY (ATWC) IN T1N0 HER2 POSITIVE BREAST CANCER-INTERIM RESULTS
    Kanjanapan, Y.
    Yip, D.
    Dahlstrom, J.
    Craft, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 57 - 57
  • [34] Reply to: Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer
    Goldhirsch, A.
    Coates, A. S.
    ANNALS OF ONCOLOGY, 2014, 25 (03) : 755 - 755
  • [35] For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures
    Zhou, Qiong
    Yin, Wenjin
    Du, Yueyao
    Lu, Jinsong
    PLOS ONE, 2014, 9 (01):
  • [36] Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
    Musolino, A.
    Falcini, F.
    Sikokis, A.
    Boggiani, D.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Zamagni, C.
    Esposti, R. Degli
    Cortesi, L.
    Bisagni, G.
    Cavanna, L.
    Frassoldati, A.
    Sgargi, P.
    Michiara, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 88 : 10 - 20
  • [37] Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers
    Musolino, Antonino
    Boggiani, Daniela
    Sikokis, Angelica
    Rimanti, Anita
    Pellegrino, Benedetta
    Vattiato, Rosa
    Sgargi, Paolo
    Falcini, Fabio
    Caminiti, Caterina
    Michiara, Maria
    Leonardi, Francesco
    CANCER TREATMENT REVIEWS, 2016, 43 : 1 - 7
  • [38] Preoperative factors that predict pathologic nodal involvement in early-stage HER2+breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery
    Faleh, Sohayb
    Prakash, Ipshita
    Salehi, Aida
    Khan, Haseeb
    Basik, Mark
    Boileau, Jean Francois
    Tejera, David
    Panet, Francois
    Martel, Karyne
    Meterissian, Sarkis
    Wong, Stephanie M.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (02) : 303 - 312
  • [39] Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?
    Liu, Dandan
    Chang, Lidan
    Hao, Qian
    Ren, Xueting
    Liu, Peinan
    Liu, Xingyu
    Wei, Yumeng
    Wang, Meng
    Wu, Hao
    Kang, Huafeng
    Lin, Shuai
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [40] Development and External Validation of a Nomogram to Predict the Benefit of Regional Node Irradiation in Patients with pT1-2N1M0 Breast Cancer
    Sun, G.
    Wen, G.
    Zhang, Y. J.
    Tang, Y.
    Jing, H.
    Zhao, X.
    Chen, S.
    Jin, J.
    Song, Y.
    Liu, Y.
    Fang, H.
    Tang, Y.
    Qi, S.
    Li, N.
    Chen, B.
    Lu, N.
    Li, Y.
    Wang, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E23 - E24
12345